New Insights into COVID-19 Vaccine Efficacy for Individuals with Celiac Disease Celiac disease (CeD) is an autoimmune condition triggered by gluten consumption, causing damage to the small intestine and increasing the risk of other autoimmune disorders. Questions have arisen regarding how individuals with CeD respond to vaccines, and while most vaccines, excluding the hepatitis B …
Topas, therapeutics company, initiates Phase IIa Trial for Celiac Disease Treatment Trial to assess symptom severity and immune tolerance after exposure to gluten. Topas Therapeutics has commenced a Phase IIa clinical trial for TPM502, a potential treatment for individuals with celiac disease, an autoimmune condition. The study, involving 42 adults diagnosed with celiac disease, will …
New Study Sheds Light on How Gluten Triggers Intestinal Damage in Celiac Disease Indulging in a bagel takes on a complex dimension for those with celiac disease—a mixture of relishing the forbidden gluten bread and anticipating the subsequent repercussions. As the bagel undergoes digestion, gliadin, a protein residing in gluten, remains in the gut, setting …
